A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome
Open Access
- 12 November 2019
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 30 (2) , 334-350
Abstract
We consider estimation in a randomised placebo-controlled or standard-of-care-controlled drug trial with quantitative outcome, where participants who discontinue an investigational treatment are not followed up thereafter, and the estimand follows a treatment policy strategy for handling treatment discontinuation. Our approach is also useful in situations where participants take rescue medication or a subsequent line of therapy and the estimand follows a hypothetical strategy to estimate the effect of initially randomised treatment in the absence of rescue or other active treatment. Carpenter et al proposed reference-based imputation methods which use a reference arm to inform the distribution of post-discontinuation outcomes and hence to inform an imputation model. However, the reference-based imputation methods were not formally justified. We present a causal model which makes an explicit assumption in a potential outcomes framework about the maintained causal effect of treatment after discontinuation. We use mathematical argument and a simulation study to show that the “jump to reference”, “copy reference” and “copy increments in reference” reference-based imputation methods, with the control arm as the reference arm, are special cases of the causal model with specific assumptions about the causal treatment effect. We also show that the causal model provides a flexible and transparent framework for a tipping point sensitivity analysis in which we vary the assumptions made about the causal effect of discontinued treatment. We illustrate the approach with data from two longitudinal clinical trials.Keywords
Funding Information
- GlaxoSmithKline (COL100038502)
- Medical Research Council (MC_UU_12023/21, U105260558)
This publication has 19 references indexed in Scilit:
- Response to Comments by Seaman et al. on “Analysis of Longitudinal Trials With Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” Journal of Biopharmaceutical Statistics 23:1352–1371Journal of Biopharmaceutical Statistics, 2014
- Comment on “Analysis of Longitudinal Trials With Protocol Deviations: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” by Carpenter, Roger, and KenwardJournal of Biopharmaceutical Statistics, 2014
- Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trialStatistics in Medicine, 2014
- Analysis of Longitudinal Trials with Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple ImputationJournal of Biopharmaceutical Statistics, 2013
- Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture modelsPharmaceutical Statistics, 2013
- A structured approach to choosing estimands and estimators in longitudinal clinical trialsPharmaceutical Statistics, 2012
- Missing Data Handling Methods in Medical Device Clinical TrialsJournal of Biopharmaceutical Statistics, 2009
- Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-upThe British Journal of Psychiatry, 2003
- Causal Effects in Clinical and Epidemiological Studies Via Potential Outcomes: Concepts and Analytical ApproachesAnnual Review of Public Health, 2000
- A Note on the Delta MethodThe American Statistician, 1992